Two Sigma Investments’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81M | Sell |
158,724
-98,801
| -38% | -$1.13M | ﹤0.01% | 1869 |
|
|
2025
Q1 | $3.06M | Buy |
257,525
+122,441
| +91% | +$1.45M | 0.01% | 1400 |
|
|
2024
Q4 | $2.54M | Buy |
135,084
+84,375
| +166% | +$1.59M | 0.01% | 1499 |
|
|
2024
Q3 | $1.14M | Sell |
50,709
-10,179
| -17% | -$229K | ﹤0.01% | 1991 |
|
|
2024
Q2 | $1.27M | Sell |
60,888
-150,428
| -71% | -$3.14M | ﹤0.01% | 1785 |
|
|
2024
Q1 | $3.11M | Buy |
211,316
+116,544
| +123% | +$1.71M | 0.01% | 1158 |
|
|
2023
Q4 | $978K | Buy |
94,772
+68,015
| +254% | +$702K | ﹤0.01% | 2022 |
|
|
2023
Q3 | $210K | Sell |
26,757
-21,371
| -44% | -$168K | ﹤0.01% | 2550 |
|
|
2023
Q2 | $481K | Buy |
48,128
+36,828
| +326% | +$368K | ﹤0.01% | 2279 |
|
|
2023
Q1 | $100K | Sell |
11,300
-25,514
| -69% | -$227K | ﹤0.01% | 2596 |
|
|
2022
Q4 | $404K | Buy |
+36,814
| New | +$404K | ﹤0.01% | 2057 |
|
|
2022
Q2 | – | Sell |
-91,335
| Closed | -$1.28M | – | 2743 |
|
|
2022
Q1 | $1.28M | Buy |
+91,335
| New | +$1.28M | ﹤0.01% | 1548 |
|